Adenomyomatosis of the gallbladder (AG) is a condition in which the inner wall of the gallbladder becomes thickened and nodular. It is a very common condition, affecting up to 10% of people in some populations. AG is often asymptomatic and is usually discovered incidentally during imaging for other issues. However, it can cause symptoms such as abdominal pain, nausea, and vomiting. In some cases, AG can lead to complications such as gallbladder cancer and cholecystitis. As such, it is important for doctors to be aware of the condition and to understand how it can be diagnosed and managed. This article will provide an overview of AG, including its causes, diagnosis, and treatment.
Adenomyomatosis of the gallbladder is a condition in which the inner wall of the gallbladder becomes thickened and nodular. It is caused by a buildup of mucus, bile, and other substances in the gallbladder. This buildup leads to the formation of small nodules, which can range in size from a few millimeters to several centimeters. AG can affect one or both sides of the gallbladder, and it can also affect different parts of the organ.
The exact cause of AG is not known. However, there are several risk factors that can increase a person’s likelihood of developing the condition. These risk factors include obesity, diabetes, and a high-fat diet. In addition, certain medications, such as steroids, can also increase the risk of developing AG.
AG is usually diagnosed during imaging tests, such as an ultrasound or CT scan. During these tests, the doctor will be able to see the thickened and nodular walls of the gallbladder. In some cases, a biopsy may also be performed to confirm the diagnosis.
In most cases, AG does not require treatment. However, if the condition is causing symptoms, it may be necessary to treat the underlying cause. For example, if the patient is overweight, they may be advised to lose weight. If the patient is taking steroids, they may be advised to stop taking them. In some cases, surgery may be necessary. This is usually only recommended if the patient is experiencing severe symptoms or if there is a risk of complications. Surgery may involve removing the gallbladder, or it may involve removing the nodules.
Adenomyomatosis of the gallbladder is a common condition that can cause symptoms such as abdominal pain, nausea, and vomiting. It is usually asymptomatic and is usually discovered incidentally during imaging tests. In most cases, AG does not require treatment, but if the patient is experiencing severe symptoms or if there is a risk of complications, surgery may be necessary. It is important for doctors to be aware of the condition and to understand how it can be diagnosed and managed.
1.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
5.
A new blood test greatly increases the ability to detect cancer.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation